Master Generative AI in Drug Discovery: From Molecular Design to Clinical Validation in 4 weeks through hands-on, project-based online training with DSTC.
AI & Machine Learning in Healthcare
Module-by-module breakdown of Generative AI in Drug Discovery: From Molecular Design to Clinical Validation, from foundations to a certified capstone project.
Outline
Understand the core concepts and importance of Generative AI in scientific research. β’ Differentiate between traditional and AI-driven drug discovery pipelines. β’ Explore key applications of AI in molecular design and lead optimization.
Outline
Learn the principles of Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs). β’ Apply GANs and VAEs for de novo molecular design and generation. β’ Conduct hands-on exercises using DeepChem/RDKit to generate novel molecules.
Outline
Utilize AI models for accurate prediction of ADMET properties, solubility, and toxicity. β’ Evaluate molecular binding affinity using advanced AI techniques. β’ Perform practical property prediction with RDKit/DeepChem.
Outline
Employ AI for efficient large-scale virtual screening of compound libraries. β’ Discover new therapeutic uses for existing drugs through AI-driven repurposing strategies. β’ Implement AI tools to screen molecules for bioactivity.
Outline
Leverage AI for toxicity assessment and efficacy prediction in preclinical studies. β’ Identify and validate biomarkers using AI for enhanced clinical understanding. β’ Predict clinical trial success rates through robust AI models.
Outline
Analyze the current challenges and future opportunities in applying AI to drug discovery. β’ Discuss the ethical considerations and responsible implementation of AI in pharmaceuticals. β’ Formulate strategies for integrating AI into real-world drug development pipelines.
e-Certificate and e-Marksheet issued on successful completion.